Dose-Finding
Showing 9976 - 10000 of >10,000
Dementia Trial in Nottingham (Singing group)
Recruiting
- Dementia
- Singing group
-
Nottingham, Nottinghamshire, United Kingdom
- +1 more
Nov 14, 2022
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156
Recruiting
- Schizophrenia
- +11 more
- LY03010 156 mg treatment group, deltoid
- +3 more
-
Little Rock, Arkansas
- +8 more
Apr 11, 2022
Non-Hodgkin's Lymphoma Trial in China (single dose of CNCT19)
Recruiting
- Non-Hodgkin's Lymphoma
- single dose of CNCT19
-
Fuzhou, Fujian, China
- +17 more
Feb 17, 2022
HCC, CKD Trial in Seoul (low dose CT contrast media, Standard dose CT contrast media)
Active, not recruiting
- HCC
- CKD
- low dose CT contrast media
- Standard dose CT contrast media
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 16, 2021
Nursing Students Trial in Cankiri (Edpuzzle interactive videos)
Completed
- Nursing Students
- Edpuzzle interactive videos
-
Cankırı, Çankırı, TurkeyCankırı Karatekin University
Aug 3, 2021
Trypanosomiasis, African Trial in Kuala Lumpur (Acoziborole, Midazolam, Dextromethorphan)
Completed
- Trypanosomiasis, African
- Acoziborole
- +2 more
-
Kuala Lumpur, MalaysiaClinical Research Center (CRC) Ampang Hospital
Jul 7, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States
Suspended
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- Cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 10, 2022
Obesity Trial in Baltimore (Web-based application connecting small food store owners and suppliers of healthier foods and
Recruiting
- Obesity
- Web-based application connecting small food store owners and suppliers of healthier foods and beverages
-
Baltimore, MarylandJohns Hopkins University
Oct 29, 2021
Hutchinson-Gilford Progeria Syndrome, Werner Syndrome Trial in Glendale (Progerinin, Placebo)
Completed
- Hutchinson-Gilford Progeria Syndrome
- Werner Syndrome
- Progerinin
- Placebo
-
Glendale, CaliforniaPRG S&T Investigational Site
Sep 15, 2021
Duchenne Muscular Dystrophy Trial in Worldwide (Placebo, SRP-4053)
Aneurysmal Subarachnoid Hemorrhage, Neurobehavioral Manifestations, Vasospasm, Intracranial Trial in United States (Continuous
Suspended
- Aneurysmal Subarachnoid Hemorrhage
- +4 more
- Continuous Low-Dose IV Unfractionated Heparin Infusion
-
New Haven, Connecticut
- +8 more
Feb 17, 2022
Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)
Terminated
- Acute Myeloid Leukemia
-
Los Angeles, California
- +7 more
Mar 14, 2022
OCD, Accelerated Continue Theta-burst Stimulation, Transcranial Magnetic Stimulation Trial in Hefei (Transcranial magnetic
Recruiting
- Obsessive-Compulsive Disorder
- +3 more
- Transcranial magnetic stimulation with real coil
-
Hefei, Anhui, ChinaAnhui Medical University
Jan 23, 2022
Chemo-induced Peripheral Neuropathy (CIPN) Trial (SON-080)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy (CIPN)
- SON-080
- (no location specified)
Jun 23, 2022
Glucocorticoids and Bone in Graves' Ophthalmopathy
Active, not recruiting
- Graves Ophthalmopathy
-
Aarhus C, Central Denmark Region, Denmark
- +1 more
Feb 21, 2022
Pharmacokinetics Trial in Sofia (Budesonide Inhalant Product)
Completed
- Pharmacokinetics
- Budesonide Inhalant Product
-
Sofia, BulgariaMC Comac Medical Ltd.
Feb 21, 2022
Hypercholesterolemia, Coronary Disease Trial (Ezetimibe/Simvastatin 10/20 mg, simvastatin 40 mg)
Completed
- Hypercholesterolemia
- Coronary Disease
- Ezetimibe/Simvastatin 10/20 mg
- simvastatin 40 mg
- (no location specified)
Feb 7, 2022
Chronic Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Greenville (eneboparatide, Placebo)
Not yet recruiting
- Chronic Hypoparathyroidism
- +2 more
- eneboparatide
- Placebo
-
Greenville, North CarolinaPhysician's East Endocrinology
Mar 9, 2023
Musculoskeletal Health in Adult Haematological Cancer Survivors
Not yet recruiting
- Lymphoma
- +3 more
- Not an intervention study
- (no location specified)
May 9, 2023
Transitional Cell Tumor, Hepatoblastoma, Liver Cancer Trial in Shanghai (PD-1 inhibitor)
Not yet recruiting
- Transitional Cell Tumor
- +4 more
- PD-1 inhibitor
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Apr 3, 2022
Odontalgia, Toothache Trial in San Antonio (Epidiolex 100 mg/mL Oral Solution, Placebo)
Recruiting
- Odontalgia
- Toothache
- Epidiolex 100 mg/mL Oral Solution
- Placebo
-
San Antonio, TexasThe University of Texas Health Science Center at San Antonio
Mar 31, 2022